Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
  • Page of 1
Girgis RR, Xu X, Gil RB, Hackett E, Ojeil N, Lieberman JA, Slifstein M, Abi-Dargham A. Antipsychotic binding to the dopamine-3 receptor in humans: A PET study with [(11)C]-(+)-PHNO. Schizophr Res. 2015 Oct;168(1-2):373-6. doi: 10.1016/j.schres.2015.06.027. Epub 2015 Jul 17. PubMed PMID: 26190300; PubMed Central PMCID: PMC4591174.
Slifstein M, van de Giessen E, Van Snellenberg J, Thompson JL, Narendran R, Gil R, Hackett E, Girgis R, Ojeil N, Moore H, D'Souza D, Malison RT, Huang Y, Lim K, Nabulsi N, Carson RE, Lieberman JA, Abi-Dargham A. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study. JAMA Psychiatry. 2015 Apr;72(4):316-24. doi: 10.1001/jamapsychiatry.2014.2414. PubMed PMID: 25651194; PubMed Central PMCID: PMC4768742.
Thompson JL, Urban N, Slifstein M, Xu X, Kegeles LS, Girgis RR, Beckerman Y, Harkavy-Friedman JM, Gil R, Abi-Dargham A. Striatal dopamine release in schizophrenia comorbid with substance dependence. Mol Psychiatry. 2013 Aug;18(8):909-15. doi: 10.1038/mp.2012.109. Epub 2012 Aug 7. PubMed PMID: 22869037; PubMed Central PMCID: PMC4128915.
Goff DC, McEvoy JP, Citrome L, Mech AW, Bustillo JR, Gil R, Buckley P, Manschreck TC, Achtyes ED, Macklin EA. High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS study. J Clin Psychopharmacol. 2013 Aug;33(4):485-90. doi: 10.1097/JCP.0b013e3182977308. PubMed PMID: 23775057.
Kayser J, Tenke CE, Kroppmann CJ, Alschuler DM, Fekri S, Gil R, Jarskog LF, Harkavy-Friedman JM, Bruder GE. A neurophysiological deficit in early visual processing in schizophrenia patients with auditory hallucinations. Psychophysiology. 2012 Sep;49(9):1168-78. doi: 10.1111/j.1469-8986.2012.01404.x. Epub 2012 Jul 16. PubMed PMID: 22803512; PubMed Central PMCID: PMC3419781.
Abi-Dargham A, Xu X, Thompson JL, Gil R, Kegeles LS, Urban N, Narendran R, Hwang DR, Laruelle M, Slifstein M. Increased prefrontal cortical D₁ receptors in drug naive patients with schizophrenia: a PET study with [¹¹C]NNC112. J Psychopharmacol. 2012 Jun;26(6):794-805. doi: 10.1177/0269881111409265. Epub 2011 Jul 18. PubMed PMID: 21768159.
Kegeles LS, Mao X, Stanford AD, Girgis R, Ojeil N, Xu X, Gil R, Slifstein M, Abi-Dargham A, Lisanby SH, Shungu DC. Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy. Arch Gen Psychiatry. 2012 May;69(5):449-59. doi: 10.1001/archgenpsychiatry.2011.1519. Epub 2012 Jan 2. PubMed PMID: 22213769; NIHMSID:NIHMS352541.
Frankle WG, Lombardo I, Kegeles LS, Slifstein M, Martin JH, Huang Y, Hwang DR, Reich E, Cangiano C, Gil R, Abi-Dargham A, Laruelle M. Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidone. J Psychopharmacol. 2011 Jun;25(6):734-43. doi: 10.1177/0269881110388329. Epub 2010 Nov 25. PubMed PMID: 21109614.
Ahn K, Gil R, Seibyl J, Sewell RA, D'Souza DC. Probing GABA receptor function in schizophrenia with iomazenil. Neuropsychopharmacology. 2011 Feb;36(3):677-83. doi: 10.1038/npp.2010.198. Epub 2010 Nov 10. PubMed PMID: 21068719; PubMed Central PMCID: PMC3055690.
Bruder GE, Alschuler DM, Kroppmann CJ, Fekri S, Gil RB, Jarskog LF, Harkavy-Friedman JM, Goetz R, Kayser J, Wexler BE. Heterogeneity of auditory verbal working memory in schizophrenia. J Abnorm Psychol. 2011 Feb;120(1):88-97. doi: 10.1037/a0021661. PubMed PMID: 21319926; PubMed Central PMCID: PMC3061570.
Kegeles LS, Slifstein M, Xu X, Urban N, Thompson JL, Moadel T, Harkavy-Friedman JM, Gil R, Laruelle M, Abi-Dargham A. Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F]fallypride positron emission tomography. Biol Psychiatry. 2010 Oct 1;68(7):634-41. doi: 10.1016/j.biopsych.2010.05.027. Epub 2010 Jul 31. PubMed PMID: 20673873; PubMed Central PMCID: PMC2952433.
Kayser J, Tenke CE, Gil R, Bruder GE. ERP generator patterns in schizophrenia during tonal and phonetic oddball tasks: effects of response hand and silent count. Clin EEG Neurosci. 2010 Oct;41(4):184-95. doi: 10.1177/155005941004100405. PubMed PMID: 21077570; PubMed Central PMCID: PMC3341098.
Kegeles LS, Abi-Dargham A, Frankle WG, Gil R, Cooper TB, Slifstein M, Hwang DR, Huang Y, Haber SN, Laruelle M. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Arch Gen Psychiatry. 2010 Mar;67(3):231-9. doi: 10.1001/archgenpsychiatry.2010.10. PubMed PMID: 20194823.
Kayser J, Tenke CE, Gil RB, Bruder GE. Stimulus- and response-locked neuronal generator patterns of auditory and visual word recognition memory in schizophrenia. Int J Psychophysiol. 2009 Sep;73(3):186-206. doi: 10.1016/j.ijpsycho.2009.02.003. Epub 2009 Mar 9. PubMed PMID: 19275917; PubMed Central PMCID: PMC2757785.
Martinez D, Slifstein M, Gil R, Hwang DR, Huang Y, Perez A, Frankle WG, Laruelle M, Krystal J, Abi-Dargham A. Positron emission tomography imaging of the serotonin transporter and 5-HT(1A) receptor in alcohol dependence. Biol Psychiatry. 2009 Jan 15;65(2):175-80. doi: 10.1016/j.biopsych.2008.08.034. Epub 2008 Oct 29. PubMed PMID: 18962444; PubMed Central PMCID: PMC2621104.
Rosenfield PJ, Girgis RR, Gil R. High-dose ziprasidone-induced acute dystonia. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):546-7. doi: 10.1016/j.pnpbp.2006.10.005. Epub 2006 Nov 22. PubMed PMID: 17123682.
Frankle WG, Lombardo I, Kegeles LS, Slifstein M, Martin JH, Huang Y, Hwang DR, Reich E, Cangiano C, Gil R, Laruelle M, Abi-Dargham A. Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [11C]WAY 100635. Psychopharmacology (Berl). 2006 Dec;189(2):155-64. doi: 10.1007/s00213-006-0543-8. Epub 2006 Sep 5. PubMed PMID: 16953380.
D'Souza DC, Gil RB, Madonick S, Perry EB, Forselius-Bielen K, Braley G, Donahue L, Tellioglu T, Zimolo Z, Gueorguieva R, Krystal JH. Enhanced sensitivity to the euphoric effects of alcohol in schizophrenia. Neuropsychopharmacology. 2006 Dec;31(12):2767-75. doi: 10.1038/sj.npp.1301207. Epub 2006 Sep 20. PubMed PMID: 16985503.
D'Souza DC, Gil RB, Zuzarte E, MacDougall LM, Donahue L, Ebersole JS, Boutros NN, Cooper T, Seibyl J, Krystal JH. gamma-Aminobutyric acid-serotonin interactions in healthy men: implications for network models of psychosis and dissociation. Biol Psychiatry. 2006 Jan 15;59(2):128-37. doi: 10.1016/j.biopsych.2005.06.020. Epub 2005 Sep 2. PubMed PMID: 16140281.
Narendran R, Frankle WG, Keefe R, Gil R, Martinez D, Slifstein M, Kegeles LS, Talbot PS, Huang Y, Hwang DR, Khenissi L, Cooper TB, Laruelle M, Abi-Dargham A. Altered prefrontal dopaminergic function in chronic recreational ketamine users. Am J Psychiatry. 2005 Dec;162(12):2352-9. doi: 10.1176/appi.ajp.162.12.2352. PubMed PMID: 16330601.
Martinez D, Gil R, Slifstein M, Hwang DR, Huang Y, Perez A, Kegeles L, Talbot P, Evans S, Krystal J, Laruelle M, Abi-Dargham A. Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol Psychiatry. 2005 Nov 15;58(10):779-86. doi: 10.1016/j.biopsych.2005.04.044. Epub 2005 Jul 14. PubMed PMID: 16018986.
Frankle WG, Narendran R, Huang Y, Hwang DR, Lombardo I, Cangiano C, Gil R, Laruelle M, Abi-Dargham A. Serotonin transporter availability in patients with schizophrenia: a positron emission tomography imaging study with [11C]DASB. Biol Psychiatry. 2005 Jun 15;57(12):1510-6. doi: 10.1016/j.biopsych.2005.02.028. PubMed PMID: 15953487.
Frankle WG, Gil R, Hackett E, Mawlawi O, Zea-Ponce Y, Zhu Z, Kochan LD, Cangiano C, Slifstein M, Gorman JM, Laruelle M, Abi-Dargham A. Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications. Psychopharmacology (Berl). 2004 Oct;175(4):473-80. doi: 10.1007/s00213-004-1852-4. PubMed PMID: 15083259.
Bruder GE, Wexler BE, Sage MM, Gil RB, Gorman JM. Verbal memory in schizophrenia: additional evidence of subtypes having different cognitive deficits. Schizophr Res. 2004 Jun 1;68(2-3):137-47. doi: 10.1016/S0920-9964(03)00156-7. PubMed PMID: 15099598.
Abi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y, Hwang DR, Keilp J, Kochan L, Van Heertum R, Gorman JM, Laruelle M. Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci. 2002 May 1;22(9):3708-19. doi: 20026302. PubMed PMID: 11978847; PubMed Central PMCID: PMC6758376.
Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS, Weiss R, Cooper TB, Mann JJ, Van Heertum RL, Gorman JM, Laruelle M. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8104-9. doi: 10.1073/pnas.97.14.8104. PubMed PMID: 10884434; PubMed Central PMCID: PMC16677.
Laruelle M, Abi-Dargham A, van Dyck C, Gil R, D'Souza DC, Krystal J, Seibyl J, Baldwin R, Innis R. Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT. Biol Psychiatry. 2000 Mar 1;47(5):371-9. doi: 10.1016/s0006-3223(99)00257-7. PubMed PMID: 10704949.
D'Souza DC, Gil R, Cassello K, Morrissey K, Abi-Saab D, White J, Sturwold R, Bennett A, Karper LP, Zuzarte E, Charney DS, Krystal JH. IV glycine and oral D-cycloserine effects on plasma and CSF amino acids in healthy humans. Biol Psychiatry. 2000 Mar 1;47(5):450-62. doi: 10.1016/s0006-3223(99)00133-x. PubMed PMID: 10704956.
Verhoeff NP, Soares JC, D'Souza CD, Gil R, Degen K, Abi-Dargham A, Zoghbi SS, Fujita M, Rajeevan N, Seibyl JP, Krystal JH, van Dyck CH, Charney DS, Innis RB. [123I]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia. Psychiatry Res. 1999 Oct 11;91(3):163-73. doi: 10.1016/s0925-4927(99)00027-x. PubMed PMID: 10641580.
Petrakis IL, Trevisan L, D'Souza C, Gil R, Krasnicki S, Webb E, Heninger G, Cooney N, Krystal JH. CSF monoamine metabolite and beta endorphin levels in recently detoxified alcoholics and healthy controls: prediction of alcohol cue-induced craving?. Alcohol Clin Exp Res. 1999 Aug;23(8):1336-41. PubMed PMID: 10470976.
Laruelle M, Abi-Dargham A, Gil R, Kegeles L, Innis R. Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry. 1999 Jul 1;46(1):56-72. doi: 10.1016/s0006-3223(99)00067-0. Review. PubMed PMID: 10394474.
Abi-Dargham A, Gil R, Krystal J, Baldwin RM, Seibyl JP, Bowers M, van Dyck CH, Charney DS, Innis RB, Laruelle M. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry. 1998 Jun;155(6):761-7. doi: 10.1176/ajp.155.6.761. PubMed PMID: 9619147.
Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9235-40. doi: 10.1073/pnas.93.17.9235. PubMed PMID: 8799184; PubMed Central PMCID: PMC38625.
What would you like to do?
  • Page of 1